Concepedia

1365TiP A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy

S. Lim, Dongwook Kim, Jae-Eon Jung, G. Lee, J.‐H. Ryou, Su Hwan Kang, Young Ho Lee, H.J. Shin, Sungwon Yum, E. K. Yim,

Annals of Oncology · 2021 · 13 citations · 0 references

DOIFull text

Open access

Concepts